-
Something wrong with this record ?
In vitro permeation of micronized and nanonized alaptide from semisolid formulations
R. Opatrilova, A. Cernikova, L. Coufalova, J. Dohnal, J. Jampilek,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 2000
Hindawi Publishing Open Access
from 2000-01-01
PubMed Central
from 2000
Europe PubMed Central
from 2000
ProQuest Central
from 2012-01-01
Open Access Digital Library
from 2001-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2012-01-03
Medline Complete (EBSCOhost)
from 2012-01-01
Health & Medicine (ProQuest)
from 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
24453907
DOI
10.1155/2013/787283
Knihovny.cz E-resources
- MeSH
- Peptides, Cyclic * chemistry pharmacology MeSH
- Skin * MeSH
- Membranes, Artificial * MeSH
- Nanoparticles chemistry MeSH
- Neuropeptides * chemistry pharmacology MeSH
- Permeability MeSH
- Swine MeSH
- Skin, Artificial * MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
This study is focused on in vitro permeation of the original Czech compound, a skin/mucosa tissue regeneration promoter, known under the international nonproprietary name "alaptide," in micronized and nanonized forms. Alaptide showed a great potential for local applications for treatment and/or regeneration of the injured skin. The above mentioned technological modifications influence the permeation of alaptide through artificial or biological membranes, such as PAMPA or skin. The permeation of micronized and nanonized form of alaptide formulated to various semisolid pharmaceutical compositions through full-thickness pig ear skin using a Franz cell has been investigated in detail. In general, it can be concluded that the nanonized alaptide permeated through the skin less than the micronized form; different observations were made for permeation through the PAMPA system, where the micronized form showed lower permeation than the nanonized alaptide.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14074323
- 003
- CZ-PrNML
- 005
- 20141006123221.0
- 007
- ta
- 008
- 141006s2013 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2013/787283 $2 doi
- 035 __
- $a (PubMed)24453907
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Opatrilova, Radka $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic.
- 245 10
- $a In vitro permeation of micronized and nanonized alaptide from semisolid formulations / $c R. Opatrilova, A. Cernikova, L. Coufalova, J. Dohnal, J. Jampilek,
- 520 9_
- $a This study is focused on in vitro permeation of the original Czech compound, a skin/mucosa tissue regeneration promoter, known under the international nonproprietary name "alaptide," in micronized and nanonized forms. Alaptide showed a great potential for local applications for treatment and/or regeneration of the injured skin. The above mentioned technological modifications influence the permeation of alaptide through artificial or biological membranes, such as PAMPA or skin. The permeation of micronized and nanonized form of alaptide formulated to various semisolid pharmaceutical compositions through full-thickness pig ear skin using a Franz cell has been investigated in detail. In general, it can be concluded that the nanonized alaptide permeated through the skin less than the micronized form; different observations were made for permeation through the PAMPA system, where the micronized form showed lower permeation than the nanonized alaptide.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a membrány umělé $7 D008567
- 650 _2
- $a nanočástice $x chemie $7 D053758
- 650 12
- $a neuropeptidy $x chemie $x farmakologie $7 D009479
- 650 12
- $a cyklické peptidy $x chemie $x farmakologie $7 D010456
- 650 _2
- $a permeabilita $7 D010539
- 650 12
- $a kůže $7 D012867
- 650 12
- $a umělá kůže $7 D017768
- 650 _2
- $a prasata $7 D013552
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Cernikova, Aneta $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic.
- 700 1_
- $a Coufalova, Lenka $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic.
- 700 1_
- $a Dohnal, Jiri $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic.
- 700 1_
- $a Jampilek, Josef $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic.
- 773 0_
- $w MED00181094 $t TheScientificWorldJournal $x 1537-744X $g Roč. 2013, č. - (2013), s. 787283
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24453907 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20141006 $b ABA008
- 991 __
- $a 20141006123658 $b ABA008
- 999 __
- $a ok $b bmc $g 1042206 $s 873235
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 2013 $c - $d 787283 $i 1537-744X $m TheScientificWorldJournal $n ScientificWorldJournal $x MED00181094
- LZP __
- $a Pubmed-20141006